FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Pantoprazole Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

165 API Suppliers, 59 USDMF, 52 CEP/COS, 50 EU WC, 20 KDMF, 28 NDC API, 85 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

INTERMEDIATES

34 Intermediate Suppliers

34 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1264 FDF Dossiers, 69 FDA Orange Book, 763 Europe, 41 Canada, 113 Australia, 71 South Africa, 207 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 40MG BASE/VIAL, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 40MG BASE, INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Minakem, 12 Evonik, 1 Rochem International Inc, 21 SPI Pharma, 7 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 4 Kirsch Pharma, 1 Panvo Organics, 1 ACG Worldwide, 6 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 35 BASF, 2 Clariant, 16 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 2 Gloria Interchem, 13 Ideal Cures, 4 Ingredion Pharma Solutions, 1 JJ Chemicals, 26 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

74 Coating Systems & Additives, 72 Fillers, Diluents & Binders, 46 Direct Compression, 40 Controlled & Modified Release, 38 Disintegrants & Superdisintegrants, 36 Solubilizers, 34 Granulation, 33 Taste Masking, 32 Thickeners and Stabilizers, 25 Film Formers & Plasticizers, 23 Chewable & Orodispersible Aids, 22 Lubricants & Glidants, 21 Topical, 21 Parenteral, 14 Co-Processed Excipients, 9 Emulsifying Agents, 7 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 63 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 348 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

71 APIs, 55 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 1 US Exclusivities, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 24 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

TABLET, DELAYED RELEASE;ORAL - EQ 40MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE

POWDER;INTRAVENOUS - EQ 40MG BASE/VIAL

INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Pantoprazole Sodium

Pantoprazole Sodium

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

165 API Suppliers

59 USDMF

52 CEP/COS

50 EU WC

20 KDMF

28 NDC API

85 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

INTERMEDIATES

34 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1264 FDF Dossiers

69 FDA Orange Book

763 Europe

41 Canada

113 Australia

71 South Africa

207 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 40MG BASE/VIAL

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 40MG BASE

INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Minakem

12 Evonik

1 Rochem International Inc

21 SPI Pharma

7 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

4 Kirsch Pharma

1 Panvo Organics

1 ACG Worldwide

6 Actylis

2 Aeon Procare

2 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

35 BASF

2 Clariant

16 Corel Pharma Chem

6 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

2 Gloria Interchem

13 Ideal Cures

4 Ingredion Pharma Solutions

1 JJ Chemicals

26 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

2 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

21 Roquette

14 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd